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http://dxObjectives: Optimizing blood pressure using near-infrared spectroscopy monitoring has been suggested to
ensure organ perfusion during cardiac surgery. Near-infrared spectroscopy is a reliable surrogate for cerebral
blood flow in clinical cerebral autoregulation monitoring and might provide an earlier warning of malperfusion
than indicators of cerebral ischemia. We hypothesized that blood pressure below the limits of cerebral
autoregulation during cardiopulmonary bypass would be associated with major morbidity and operative
mortality after cardiac surgery.
Methods: Autoregulation was monitored during cardiopulmonary bypass in 450 patients undergoing coronary
artery bypass grafting and/or valve surgery. A continuous, moving Pearson’s correlation coefficient was
calculated between the arterial pressure and low-frequency near-infrared spectroscopy signals and displayed
continuously during surgery using a laptop computer. The area under the curve of the product of the duration
and magnitude of blood pressure below the limits of autoregulation was compared between patients with
and without major morbidity (eg, stroke, renal failure, mechanical lung ventilation>48 hours, inotrope use
>24 hours, or intra-aortic balloon pump insertion) or operative mortality.
Results: Of the 450 patients, 83 experienced major morbidity or operative mortality. The area under the curve
of the product of the duration and magnitude of blood pressure below the limits of autoregulation was indepen-
dently associated with major morbidity or operative mortality after cardiac surgery (odds ratio, 1.36; 95%
confidence interval, 1.08-1.71; P ¼ .008).
Conclusions: Blood pressure management during cardiopulmonary bypass using physiologic endpoints such as
cerebral autoregulation monitoringmight provide a method of optimizing organ perfusion and improving patient
outcomes from cardiac surgery. (J Thorac Cardiovasc Surg 2014;147:483-9)Currently, no consensus exists on the optimal mean arterial
pressure (MAP) for patients during cardiopulmonary
bypass (CPB). The current standard of care of empirically
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Mautoregulation remains functional during CPB when
a-stat pH management is used.1,2 Thus, a MAP as low as
50 mm Hg has traditionally been believed to be well
tolerated, because the CBF has not been compromised.1,3
Whether this approach is appropriate for the increasing
number of elderly patients and for those with comorbidities
that increase the risk of neurologic and other complications
has been questioned. Our group has performed clinical
studies of patients during CPB in which CBF auto-
regulation was monitored continuously in real time.4-8 We
have found in a contemporary cohort of patients that the
lower limit of autoregulation varies widely (from 40 to 90
mm Hg) and is difficult to predict from the preoperative
blood pressure and patient demographics.4,7 Furthermore,
as many as 20% of patients will have impaired auto-
regulation during CPB that results in pressure-passive CBF,
particularly during patient rewarming after hypothermia.6,8
This condition was associated with an elevated risk of
stroke.6,8
Maneuvers aimed at optimizing cerebral perfusion will
also influence systematic perfusion. This has led to the
notion that the brain might serve as an index organ for
ensuring other organ oxygenation during CPB.9 Severalrdiovascular Surgery c Volume 147, Number 1 483
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CBF ¼ cerebral blood flow
CPB ¼ cardiopulmonary bypass
MAP ¼ mean arterial pressure
MMOM ¼ major morbidity and operative mortality
NIRS ¼ near-infrared spectroscopy
COx ¼ cerebral oximetry index
rScO2 ¼ regional cerebral oxygen saturation
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Minvestigations have shown a relationship between decre-
ments in regional cerebral oxygen saturation (rScO2)
measured using near-infrared spectroscopy (NIRS) and
neurologic and non-neurologic complications after cardiac
surgery, including the length of hospitalization.10-12
Autoregulation can be clinically assessed at the bedside
by evaluating the continuous correlation between the
metrics of CBF and MAP.13 In laboratory and clinical
studies, we have shown that low-frequency changes in the
relationship between the rScO2, measured using NIRS,
and MAP can serve as a surrogate for CBF in clinical
autoregulation monitoring.5,14 Because NIRS monitoring
is noninvasive, requires little caregiver intervention, and is
not associated with the limitations of other CBF
monitoring modalities, our methods could be used in a
wide variety of clinical settings. The finding that the limit
of autoregulation varies widely among individuals
suggests that empiric MAP management during CPB will
invariably result in some patients having a MAP below
the autoregulation threshold for at least a part of the
surgery.7 Knowing whether the MAP variations outside
the autoregulatory range are associated with adverse patient
outcomes after cardiac surgery could provide insights into
potentially modifiable risk factors for adverse patient
events. Major organ complications and mortality are
common metrics for evaluating the quality of patient care
after cardiac surgery.15 In the present study, we hypothe-
sized that the duration and magnitude of MAP outside the
CBF autoregulatory range would be associated with major
organ morbidity and mortality after cardiac surgery.METHODS
The institutional review board of Johns Hopkins Medical Institutions
approved the present study (clinical trial registration no. NCT
00981474), which was performed after patients had provided written
informed consent. Patients were eligible for the study if they were
undergoing elective coronary artery bypass grafting (CABG) and/or valve
surgery at Johns Hopkins Hospital and required CPB.
Patient Care
The patients received routine perioperative care that included invasive
radial artery blood pressure monitoring and an anesthetic that consisted
of midazolam, fentanyl, and isoflurane, along with a skeletal muscle484 The Journal of Thoracic and Cardiovascular Surgrelaxant, as previously described.4,6,8,16 The patients received
nonpulsatile CPB with a nonocclusive roller pump, a membrane
oxygenator with flow of 2.0 to 2.4 L/min/m2, and a-stat pH
management. In-line arterial blood gas was monitored continuously, and
the oxygen/air mixture to the oxygenator was varied to maintain normocar-
bia. Aspects of patient management such as the target MAP and the rate of
patient rewarming were determined by standard practice and not dictated
by the study protocol. The patients received standard postoperative care,
including continuous electrocardiographic monitoring in the intensive
care unit and on the postoperative ward.
NIRS-Based Autoregulation Monitoring
Before anesthesia was induced, the patients were connected to an NIRS
monitor (INVOS, Somanetics, Inc, Boulder, Colo) using sensors placed on
the right and left sides of the forehead. The acquisition and analysis
methods for processing the NIRS signals and MAP have been previously
described.4,6 In brief, analog arterial blood pressure signals were
digitized and then processed with the digital NIRS signals using a
personal computer and ICMþ software (University of Cambridge,
Cambridge, UK). The signals were filtered as nonoverlapping 10-second
mean values that were time-integrated, a method equivalent to applying a
moving average filter with a 10-second window and resampling at
0.1 Hz. The purpose of this process was to eliminate the high-frequency
components (eg, respiration and pulse waveforms). Additional high-pass
filtering was performed, with a dual channel cutoff set at 0.003 Hz to
remove drifts, such as those resulting from hemodilution. A continuous,
moving Pearson’s correlation coefficient between the MAP and NIRS
signals was then calculated to generate the variable cerebral oximetry
index (COx). Each calculation was performed with consecutive, paired,
10-second averaged values from 300 seconds duration, incorporating
30 data points for each index.4,6 When the MAP was within the limits of
CBF autoregulation, the COx will approach 0; however, when the MAP
is outside the limits of autoregulation, the COx will approach 1,
indicating that the CBF is blood pressure passive.
Outcome Definitions
The primary endpoint of the present study was major morbidity and
operative mortality (MMOM) using the Society of Thoracic Surgeons
National Cardiac Surgery Database definitions. This endpoint consisted
of operative death (ie, all deaths that occurred during the hospitalization
in which the operation was performed, even if after 30 days, and deaths
that occurred after discharge from the hospital but within 30 days of the
procedure, unless the cause of death was clearly unrelated to the operation),
stroke, renal failure (new requirement for dialysis postoperatively or
increase in creatinine to>2 mg/dL and 2 times greater than baseline),
mechanical lung ventilation>48 hours, or low cardiac output syndrome
(inotrope use >24 hours or new requirement for intra-aortic balloon
pump insertion).17,18 We considered the baseline serum creatinine to be
the last result before surgery, as measured in the Clinical Chemistry
Laboratory of Johns Hopkins Hospital (Roche Diagnostics, Indianapolis,
Ind). The lower sensitivity of this assay is 0.1 mg/dL. The estimated
glomerular filtration rate was calculated using the simplified
Modification of Diet in Renal Disease (MDRD) formula.19
Statistical Analysis
The patients included in the present study were participants in several
investigations.4,7,8,16 No sample size calculations were performed for our
retrospective database analysis. The autoregulation threshold was
determined using previously described methods.4,14,16 In brief, the COx
values for each patient during CPB were placed into 5-mm Hg MAP
bins. The exact COx denoting the limit of autoregulation threshold is not
clear. The highest MAP associated with COx0.3 was chosen as the lower
limit of autoregulation on the basis of previous investigations.4,14 Clinical
COx recordings during CPB that illustrate the autoregulation thresholds areery c January 2014
Ono et al Perioperative Managementshown in Figure 1. In some patients, the COx was0.3 at all MAP values,
indicating impairment of normal autoregulation.8 In those instances, the
MAP associated with the lowest COx was denoted as the optimal MAP
according to similar methods used for patients with traumatic brain
injury.20 Periods of MAP below the limit of autoregulation were expressed
in terms of magnitude (mm Hg) and duration (minutes). They are reported
as the area under the curve of the product of MAP and time normalized for
hours of CPB (AUCMAP<LLA, where LLA is the lower limit of autoregula-
tion) in units of mm Hg 3 min/h.21
The patients were categorized according to whether they had
experienced the primary endpoint of MMOM. The continuous data
between patients with and without this endpoint were compared using
analysis of variance and with Bonferroni’s correction when multiple
comparisons were performed. Fisher’s exact test was used for comparison
of dichotomous data. Non-normally distributed data were log transformed
before analysis. Multivariate logistic regression analysis was then
performed for variables with P< .1 on univariate analysis. Statistical
analysis was performed using Stata software, version 11 (StataCorp LP,
College Station, Tex).
RESULTS
Autoregulation was monitored in 450 patients. The
preoperative and operative patient characteristics are listed
in Table 1. A dysregulated pattern (COx 0.3 at all MAPs)
was observed in 83 patients (19%), similar to that reported
previously.8 Thirteen patients who required hemodialysis
before surgery were excluded from the analysis. Of theFIGURE 1. Cerebral oximetry index (COx) monitoring results during cardiopu
(l) and right (r) regional cerebral oxygen saturation (rScO2). Middle 2 channels
time spent at each 5-mm Hg bin. COx represents the value for the Pearson’s cor
arterial pressure. In the example shown, the lower limit of autoregulation, de
0.3 was 75 mm Hg. Similar displays of COx shown continuously during sur
associated with preserved cerebral autoregulation.
The Journal of Thoracic and Caremaining 437 patients, 83 (19.0%) developed the
MMOM endpoint after surgery. A history of stroke,
diabetes, congestive heart failure, impaired left ventricular
function, previous cardiac surgery, and b-blocker use
were more common in those with MMOM than in those
without MMOM. Patients who developed MMOM had
higher preoperative creatinine, a lower estimated glomer-
ular filtration rate, a longer CPB duration, longer aortic
crossclamping, and a longer hospitalization stay than did
patients without major postoperative complications.
The rScO2 and autoregulation results are listed in Table 2.
The average MAP during CPB was similar between those
who did and did not develop MMOM. Additionally, the
lower limit of CBF autoregulation was similar between
patients with and without MMOM. However, the area under
the curve for MAP below the lower limit of autoregulation
was larger for patients with MMOM than for those without
MMOM (median, 6.5 mm Hg3min/h; interquartile range,
2.1-15.4; vs median, 2.4 mm Hg 3 min/h; interquartile
range, 1.1-5.7; P ¼ .017). The rate of each complication
that constituted the MMOM endpoint is listed in Table 3.
The area under the curve of the product of the duration
and magnitude of MAP below the lower limit of autoregu-
lation between patients with and without each specificlmonary bypass. Top channel, Mean arterial blood pressure (ABP) and left
, Right and left COx results are shown. Bottom channel, the percentage of
relation coefficient between the low-frequency changes in rScO2 and mean
fined as the mean arterial pressure at which COx increased from<0.3 to
gery on a laptop computer enabled clinicians to assess the blood pressure
rdiovascular Surgery c Volume 147, Number 1 485
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TABLE 1. Patient characteristics stratified by major morbidity and
operative mortality
Characteristic
No MMOM
(n ¼ 354)
MMOM
(n ¼ 83)
P
value
Age (y) 66  11 68  11 .132
Male gender 264 (74.6) 61 (73.5) .889
Baseline creatinine (mg/dL) 1.0  0.3 1.2  0.4 <.001
Baseline eGFR
(mL 3 min1 3 1.73 m2)
81  23 69  24 <.001
Previous stroke 26 (7.3) 12 (14.5) .050
COPD 35 (9.9) 10 (12.0) .545
Current smoker 56 (15.8) 8 (9.6) .171
PVD 40 (11.3) 13 (15.7) .267
Hypertension 266 (75.1) 67 (80.7) .505
Diabetes 125 (35.3) 41 (49.4) .023
Congestive heart failure 45 (12.7) 23 (27.7) .001
Prior myocardial infarction 90 (25.4) 22 (26.5) .889
Preoperative LV ejection fraction 53  12 47  16 <.001
Previous cardiac surgery 21 (5.9) 11 (13.3) .033
Aspirin 239 (67.7) 63 (76.8) .112
b-Blockers 196 (55.5) 58 (70.7) .013
ACEIs 122 (34.6) 30 (36.6) .797
Statins* 216 (61.2) 53 (64.6) .615
Baseline pulse pressure (mm Hg) 65  19 64  17 .818
Pulse pressure 60 mm Hg 204 (58.5) 49 (59.8) .805
Type of surgery .071
CABG 221 (62.4) 41 (49.4)
CABG þ AVR and/or MVR 46 (13.0) 16 (19.3)
AVR and/or MVR 78 (22.0) 21 (25.3)
Other 9 (2.5) 5 (6.0)
Operative data
CPB duration (min) 106  38 133  64 <.001
Crossclamp (min) 67  27 77  38 .008
Hospital stay (d) <.001
Median 6.5 11
Interquartile range 5-9 7-18
Data presented as mean  SD or n (%), unless otherwise noted. MMOM, Major
morbidity and operative mortality; eGFR, estimated glomerular filtration rate;
CVA, cerebral vascular accident; COPD, chronic obstructive pulmonary disease;
PVD, peripheral vascular disease; LV, left ventricular; ACEIs, angiotensin-
converting enzyme inhibitors; CABG, coronary artery bypass grafting; AVR, aortic
valve replacement;MVR, mitral valve replacement or repair; CPB, cardiopulmonary
bypass. *Statins included HMG-coenzyme A reductase inhibitors.
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Mcomplication is also listed. Patients who developed stroke
(P ¼ .056), renal failure (P ¼ .03), and prolonged mechan-
ical ventilation (P<.001) had a greater AUCMAP<LLA than
did patients without these complications.
The factors independently associated with MMOM are
listed in Table 4. The area under the curve of the product
of the duration and magnitude of MAP less than the lower
limit of CBF autoregulation was an independent risk factor
for MMOM after cardiac surgery (odds ratio, 1.36; 95%
confidence interval, 1.08-1.71; P ¼ .008).DISCUSSION
Blood flow to the brain is normally autoregulated to
ensure a steady supply of oxygenated blood to meet the486 The Journal of Thoracic and Cardiovascular Surgmetabolic demands. The lower limit of autoregulation can
be affected by many conditions that result from vascular
disease, including hypertension and previous stroke.22
Because these conditions have widespread pathophysio-
logic consequences, it is logical that other organs, in
addition to the brain, might require higher blood pressure
to ensure organ perfusion during CPB in affected patients.
In the present study, we found a relationship between the
product of the duration and magnitude of MAP below the
limits of cerebral autoregulation and MMOM. Our
findings suggest that maintainingMAPwithin the autoregu-
latory range for the brain will ensure perfusion to other
organs, particularly the kidney, whose blood flow is also
autoregulated.23
Our results are consistent with those of others who found
improved outcomes after cardiac surgery for patients whose
treatment during CPB included manipulating MAP accord-
ing to the rScO2 monitoring results. In a prospectively
randomized study of 200 patients undergoing CABG,
Murkin and colleagues11 found that patients receiving an
intervention for rScO2 decrements during CPB had a lower
frequency of the composite outcome of operative death,
lung ventilation>48 hours after surgery, stroke, myocardial
infarction, or mediastinal re-exploration compared with
control patients when clinicians were unaware of the
NIRS results (P ¼ .048). In a randomized study of 122
patients aged >65 years undergoing abdominal surgery,
Casati and colleauges12 found that control patients
receiving blinded NIRS monitoring with intraoperative
desaturation had a longer time until postanesthesia care
unit discharge and longer hospitalization than did patients
who had received active intervention for rScO2 decrements.
In those studies, renal injury endpoints were not included in
the composite outcomes. Furthermore, our methods of
monitoring COx might indicate insufficient organ perfusion
earlier than rScO2 desaturation, which would indicate the
presence of conditions of inadequate cerebral oxygen
supply in relation to demand. This earlier warning might
explain why we found a stronger relationship between
hypotension defined by COx monitoring and MMOM
than did previous studies that evaluated only rScO2.
Because CBF autoregulation is functional during CPB
when a-stat pH management is used, clinicians have
traditionally believed a MAP of 50 mm Hg or even lower
to be adequate, because the blood to the brain is relatively
constant.1,3,24,25 Other data from Gold and colleagues26
have suggested that MAP targets during CPB of 80 to
100 mm Hg might lower the combined frequency of stroke
and myocardial outcomes compared with MAP targeted to
50 to 60 mmHg. However, those data have been questioned
because of the high stroke rate in the control group
(7.2%) and the failure to ensure compliance with MAP
management.27 The limits of autoregulation during CPB
vary widely; thus, empirically targeting higher MAPery c January 2014
TABLE 2. Blood pressure, regional cerebral oxygen saturation, and cerebral oximetry index autoregulation data stratified by major morbidity or
mortality
Variable No MMOM (n ¼ 354) MMOM (n ¼ 83) P value
Average MAP during CPB (mm Hg) 74  8 (73-75) 75  9 (72-76) .203
Average rScO2 54  11 (52-55) 55  7 (53-56) .388
Average COx 0.27  0.18 (0.25-0.29) 0.26  0.17 (0.21-0.29) .749
LLA (mm Hg) 69  14 (67-70) 71  12 (67-72) .136
AUCMAP<LLA (mm Hg 3 min/h) 2.4 (1.1-5.7) 6.5 (2.1-15.4) .017
Data reported as mean SD (95% confidence intervals), except for AUCMAP<LLA, which is reported as the median (25%-75% interquartile range).MMOM,Major morbidity and
operative mortality;MAP,mean arterial pressure; CPB, cardiopulmonary bypass; rScO2, regional cerebral oxygen saturation; COx, cerebral oximetry index; LLA, lower limit of
autoregulation; AUCMAP<LLA, area under the curve of MAP less than the LLA during CPB.
Ono et al Perioperative Managementthresholds might not necessarily be recommended, because
such a strategy could result in MAPs greater than the
upper autoregulation threshold in some patients.28 In this
situation, a higher MAP will result in an unnecessarily
high CBF that could increase the cerebral embolic load
and promote cerebral edema if CPB-associated systemic
inflammation is present.24,29 Defining the optimal MAP
during CPB might be more precise when physiologic
endpoints are used than when empiric MAP management
is used, particularly for the increasing proportion of
patients with cerebral vascular disease.30,31
Given the low rate of operative mortality as an endpoint,
major complications have been increasingly included as a
metric for evaluating the quality of care for patients
undergoing cardiac surgery.15 Our rate of MMOM (19%)
was greater than that previously reported by the Society
of Thoracic Surgeons National Cardiac Surgery Database
(13.4%).15 We focused on the complications likely to be
influenced at least in part by organ perfusion but did not
include other complication metrics such as sternal wound
infection. Our findings can be contrasted with the more
recent updates of these outcomes after CABG-only surgery,
for which the rates of operative mortality, stroke, and
prolonged mechanical lung ventilation have been reported
to have declined to 1.9%, 1.2%, and 5.9%, respectively,
from 2000 to 2009.32 Our higher rates of MMOM can likely
be explained by the higher risk cohort and the inclusion of
procedures in addition to CABG-only surgery. Nonetheless,
the factors we found associated with MMOM are consistent
with those of previous investigations. One such factor is
preoperative renal dysfunction, which has been found toTABLE 3. Specific complication rates for patients withmajormorbidity and
mean arterial pressure below the lower limit of cerebral blood flow autore
Complication Patients (n) W
Stroke 18 (4.1)
Renal failure 16 (3.6)
Mechanical ventilation>48 h 31 (7.1)
Inotrope use>24 h or new IABP insertion 47 (10.8)
Operative death 15 (3.4)
Data presented as n (%) or mean  standard deviation. AUCMAP<LLA, Area under the
cardiopulmonary bypass; IABP, intra-aortic balloon pump.
The Journal of Thoracic and Cabe associated with the risk of death, subsequent myocardial
infarction, and revascularization even up to 2 years after
CABG.33 The frequency of renal failure in our study
(3.6%) was similar to that reported by Shroyer and
colleagues15 from the Society of Thoracic Surgeons
database (3.53%).
In a report by El Bardissi and colleagues32 that docu-
mented improvements in the national trends of operative
mortality and complications, the frequency of renal failure
after CABG actually increased by 5.5% from 2000 to 2009.
Thus, modifying the risk of this complication would be
highly clinically relevant. The present results complement
our previous analysis in which we found a relationship
between excursions ofMAP below the autoregulatory limits
and acute kidney injury using the sensitive RIFLE (risk,
injury, failure, loss, and end-stage kidney disease)
criteria.16,34,35 In that study, acute kidney injury occurred
within 7 days of surgery in 34.8% of 348 patients. Using
a similar approach, we found that the duration and
magnitude by which MAP was below the lower limit of
autoregulation (mm Hg 3 min/h of CPB) were indepen-
dently associated with the risk of acute kidney injury
(relative risk, 1.02; 95% confidence interval, 1.01-1.03;
P< .0001). Most of the episodes of acute kidney injury
(84%) were of the ‘‘risk’’ category, defined as an increase
in plasma creatinine 3 1.5 or a decrease in the estimated
glomerular filtration rate by >25% from baseline. The
present study has extended those findings to a clinically
monitored endpoint of MMOM that used a more strict
definition of renal failure (new requirement for dialysis
postoperatively or increase in creatinine to>2 mg/dL andmortality after surgery and relationship to duration andmagnitude of
gulation measured with the cerebral oximetry index
AUCMAP<LLA (mm Hg 3 min/h)
P valueith complication Without complication
20.2  26.5 9.5  9.3 .056
15.5  12.7 9.7  10.6 .030
16.5  15.1 9.4  10.2 <.001
11.7  13.1 9.7  10.4 .108
15.1  19.1 9.8  10.3 .081
curve of mean arterial pressure less than the lower limit of autoregulation during
rdiovascular Surgery c Volume 147, Number 1 487
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TABLE 4. Variables independently associated with major organ
morbidity and mortality on multivariate logistic regression analysis*
Variable OR P value 95% CI
Baseline eGFR 0.98 <.001 0.97-0.99
Previous stroke 2.42 .035 1.07-5.51
Diabetes 1.64 .087 0.93-2.89
Preoperative LV ejection fraction 0.96 <.001 0.95-0.98
b Blockers 2.31 .006 1.27-4.21
Type of surgery 1.63 .001 1.22-2.19
AUCMAP<LLA (mmHg 3 min/h) 1.36 0.008 1.08-1.71
OR, Odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate;
LV, left ventricular; AUCMAP<LLA, area under the curve of mean arterial pressure
less than the lower limit of autoregulation during cardiopulmonary bypass. *The
area under receiver operating characteristic curve, 0.7601.
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M2 3 baseline) and other indicators of multiorgan
dysfunction.
Although we found a relationship between the product of
the duration and magnitude of MAP below the autoregula-
tion threshold during CPB and the risk of MMOM, we
were not able to infer a direct causal relationship between
MAP and the included outcomes. Our methods of autoregu-
lation monitoring might merely have identified patients at
greater risk of organ injury that might or might not be modi-
fied by individualized MAP management. Nonetheless, in
the present study, the lower limit of autoregulation was not
different between patients with and without MMOM.
Furthermore, the association between the duration and
magnitude of MAP below the autoregulation threshold and
the risk forMMOMpersisted after adjusting for other impor-
tant covariates. The etiology of renal injury after cardiac sur-
gery is likely multifactorial and could include exposure to
nephrotoxins, emboli, inflammation, and other causes. Simi-
larly, the etiology of stroke is multifactorial and can result
from macro- or microembolism and can be exacerbated by
inflammation from CPB.2 Hypoperfusion, however, might
contribute to injury of both organs. Experiments in piglets,
for example, have shown that renal blood flow is nearly
25% of baseline during hemorrhagic shock before the limits
of CBF autoregulation have been reached.23 Thus, preemp-
tive MAP management using COx monitoring might have a
plausible mechanistic basis for modifying these risks.
In conclusion, we found a relationship between the
duration and magnitude of MAP below the limits of
cerebral autoregulation during CPB and the risk of
MMOM. This finding suggests that blood pressure manage-
ment during CPB using physiologic endpoints such as
cerebral autoregulation monitoring might provide a method
for optimizing organ perfusion and potentially improving
patient outcomes after cardiac surgery.
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